Yongming Zhou
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Yongming Zhou has a total of 47 co-authors. Here are the top co-authors by number of shared publications:
- Hailin Chen
Department of Hematology, Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, China
3 shared publications - Jiahui Lu
Institute of Hematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai, China
3 shared publications - Jiahui Lu
Department of Haematology, Yueyang Hospital, No. 110, Ganhe Road, Shanghai 200437, China
2 shared publications Qi Hu
Department of Haematology, Shanghai Municipal Hospital of Traditional Chinese Medicine, Shanghai University of Traditional Chinese Medicine, 274 Zhijiang Middle Road, Shanghai 200071, China
2 shared publicationsQing Zeng
Department of Haematology, Yue Yang Hospital of Integrative Chinese and Western Medicine Affiliated to Shanghai University of Traditional Chinese Medicine, 110 Ganhe Road, Shanghai 200437, China
2 shared publicationsShao-Hong Zhou
Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine, Shanghai 200437, China
2 shared publications
Latest Publications
- Open Access
- 30 October 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1897026
AI-assisted single-cell transcriptomics defines immunosuppressive ecosystem states and CD274-centered communication networks in myelodysplastic syndrome
Background: Defining the transcriptional ecosystem states that govern immune dysfunction in myelodysplastic syndromes (MDS) is critical for identifying mechanistically grounded therapeutic targets in this heterogeneous hematopoietic malignancy. The MDS bone marrow immune ecosystem undergoes profound disease-associated remodeling that shifts from immune-mediated hematopoietic suppression in early disease to a globally immunosuppressive state that enables malignant clone expansion, yet the ecosystem-state architecture underlying this transition remains incompletely characterized. Methods: We deployed an AI-assisted single-cell transcriptomic analytical pipeline—integrating unsupervised Leiden machine learning clustering, multi-modal dimensionality reduction (UMAP, t-SNE, PCA), pathway module scoring, and ligand-receptor inference—on public bone marrow mononuclear cell datasets (GSE241417 as primary MDS scRNA-seq cohort; GSE120221 as external healthy bone marrow reference) to define immune ecosystem states across 11 transcriptionally distinct cell populations. Disease-associated T/NK-cell ecosystem state remodeling, immunosuppressive cytokine and checkpoint programs, and CD274-centered intercellular communication networks were systematically characterized. Key immune regulatory genes (IL10, TGFB1, CD274, FOXP3) were validated by RT-PCR in MDS-derived cell lines, and CD274 perturbation experiments were performed to investigate its regulatory role in shaping immunosuppressive ecosystem programs. Results: Eleven transcriptionally distinct immune ecosystem states were resolved within the MDS bone marrow microenvironment, with disease-associated redistribution toward cytotoxic and exhaustion-like T/NK programs. Pathway analysis revealed enrichment of T cell activation, interferon response, and cytokine signaling across ecosystem states. CD274-high cells were associated with elevated TGFB, checkpoint, and immunoregulatory module scores, while computationally inferred CD274-PDCD1 communication coexisted with TGFB1-TGFBR, LGALS9-HAVCR2, and IL10-related axes, suggesting a multi-layered immunosuppressive network. RT-PCR confirmed increased IL10, TGFB1, and CD274 expression in both MDS-derived cell lines; FOXP3 was significantly increased in SKM-1 but not significantly changed in MUTZ-1. CD274 perturbation was associated with marked IL-10 changes in SKM-1, whereas knockdown produced little apparent IL-10 reduction in MUTZ-1; FOXP3 responses were also cell-line dependent. Conclusion: This study defines the MDS bone marrow immune ecosystem at single-cell resolution using AI-assisted transcriptomic analysis, identifying CD274 as a molecule associated with immunosuppressive ecosystem programs. The findings support a hypothesis-generating model in which CD274-associated signaling may coexist with cytokine and checkpoint communication networks in MDS and may inform future ecosystem-focused therapeutic studies. Further validation using primary patient-derived immune subsets and protein-level assays is required.
- 30 October 2026
- Published by Frontiers Media SA in Frontiers in Cell and Developmental Biology
- Vol. 14, 1897026
Open AccessAI-assisted single-cell transcriptomics defines immunosuppressive ecosystem states and CD274-centered communication networks in myelodysplastic syndrome
Background: Defining the transcriptional ecosystem states that govern immune dysfunction in myelodysplastic syndromes (MDS) is critical for identifying mechanistically grounded therapeutic targets in this heterogeneous hematopoietic malignancy. The MDS bone marrow immune ecosystem undergoes profound disease-associated remodeling that shifts from immune-mediated hematopoietic suppression in early disease to a globally immunosuppressive state that enables malignant clone expansion, yet the ecosystem-state architecture underlying this transition remains incompletely characterized. Methods: We deployed an AI-assisted single-cell transcriptomic analytical pipeline—integrating unsupervised Leiden machine learning clustering, multi-modal dimensionality reduction (UMAP, t-SNE, PCA), pathway module scoring, and ligand-receptor inference—on public bone marrow mononuclear cell datasets (GSE241417 as primary MDS scRNA-seq cohort; GSE120221 as external healthy bone marrow reference) to define immune ecosystem states across 11 transcriptionally distinct cell populations. Disease-associated T/NK-cell ecosystem state remodeling, immunosuppressive cytokine and checkpoint programs, and CD274-centered intercellular communication networks were systematically characterized. Key immune regulatory genes (IL10, TGFB1, CD274, FOXP3) were validated by RT-PCR in MDS-derived cell lines, and CD274 perturbation experiments were performed to investigate its regulatory role in shaping immunosuppressive ecosystem programs. Results: Eleven transcriptionally distinct immune ecosystem states were resolved within the MDS bone marrow microenvironment, with disease-associated redistribution toward cytotoxic and exhaustion-like T/NK programs. Pathway analysis revealed enrichment of T cell activation, interferon response, and cytokine signaling across ecosystem states. CD274-high cells were associated with elevated TGFB, checkpoint, and immunoregulatory module scores, while computationally inferred CD274-PDCD1 communication coexisted with TGFB1-TGFBR, LGALS9-HAVCR2, and IL10-related axes, suggesting a multi-layered immunosuppressive network. RT-PCR confirmed increased IL10, TGFB1, and CD274 expression in both MDS-derived cell lines; FOXP3 was significantly increased in SKM-1 but not significantly changed in MUTZ-1. CD274 perturbation was associated with marked IL-10 changes in SKM-1, whereas knockdown produced little apparent IL-10 reduction in MUTZ-1; FOXP3 responses were also cell-line dependent. Conclusion: This study defines the MDS bone marrow immune ecosystem at single-cell resolution using AI-assisted transcriptomic analysis, identifying CD274 as a molecule associated with immunosuppressive ecosystem programs. The findings support a hypothesis-generating model in which CD274-associated signaling may coexist with cytokine and checkpoint communication networks in MDS and may inform future ecosystem-focused therapeutic studies. Further validation using primary patient-derived immune subsets and protein-level assays is required.
- Open Access
- 1 August 2025
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 19, 7099-7109
Synergistic Mechanisms of Traditional Chinese Medicine and Proteasome Inhibitors in Multiple Myeloma Therapy: A Comprehensive Review
Background: Multiple myeloma (MM) is a clonal plasma cell malignancy characterized by bone marrow infiltration, monoclonal immunoglobulin production, and multisystem damage. Proteasome inhibitors (PIs) such as bortezomib, carfilzomib, and ixazomib have significantly improved progression-free and overall survival in MM patients. However, drug resistance and adverse effects—including peripheral neuropathy and cardiotoxicity—remain major limitations to long-term disease control. Objective: This review aims to comprehensively evaluate the synergistic mechanisms and therapeutic potential of Traditional Chinese Medicine (TCM) in combination with PIs for the treatment of MM, from molecular insights to translational outcomes. Methods and Scope: We synthesized findings from preclinical studies, pharmacological investigations, and cohort analyses that examine the interplay between TCM bioactives and PI-based regimens. Focus is given to the modulation of MM-related signaling pathways (eg, NF-κB, STAT3, PI3K/Akt), apoptotic cascades, proteasomal degradation processes, and the bone marrow microenvironment. Results: Evidence suggests that specific TCM compounds—such as curcumin, baicalein, icariin, and berberine—can potentiate PI-induced cytotoxicity, reverse resistance mechanisms, reduce inflammatory damage, and protect against PI-associated toxicities. Several Chinese herbal formulations, including Fuzheng Peiyuan and Huanglian Jiedu decoctions, have demonstrated immunomodulatory and anti-myeloma effects in vivo and in human cohorts. These synergistic actions may enhance the efficacy and tolerability of PIs in MM therapy. Conclusion: Integrating TCM with proteasome inhibitors represents a promising strategy to optimize MM treatment by simultaneously targeting malignant cells and the tumor microenvironment. Further mechanistic research and well-designed clinical trials are warranted to validate and standardize this combinational approach for broader clinical adoption.
- 1 August 2025
- Published by Taylor & Francis in Drug Design, Development and Therapy
- Vol. ume 19, 7099-7109
Open AccessSynergistic Mechanisms of Traditional Chinese Medicine and Proteasome Inhibitors in Multiple Myeloma Therapy: A Comprehensive Review
Background: Multiple myeloma (MM) is a clonal plasma cell malignancy characterized by bone marrow infiltration, monoclonal immunoglobulin production, and multisystem damage. Proteasome inhibitors (PIs) such as bortezomib, carfilzomib, and ixazomib have significantly improved progression-free and overall survival in MM patients. However, drug resistance and adverse effects—including peripheral neuropathy and cardiotoxicity—remain major limitations to long-term disease control. Objective: This review aims to comprehensively evaluate the synergistic mechanisms and therapeutic potential of Traditional Chinese Medicine (TCM) in combination with PIs for the treatment of MM, from molecular insights to translational outcomes. Methods and Scope: We synthesized findings from preclinical studies, pharmacological investigations, and cohort analyses that examine the interplay between TCM bioactives and PI-based regimens. Focus is given to the modulation of MM-related signaling pathways (eg, NF-κB, STAT3, PI3K/Akt), apoptotic cascades, proteasomal degradation processes, and the bone marrow microenvironment. Results: Evidence suggests that specific TCM compounds—such as curcumin, baicalein, icariin, and berberine—can potentiate PI-induced cytotoxicity, reverse resistance mechanisms, reduce inflammatory damage, and protect against PI-associated toxicities. Several Chinese herbal formulations, including Fuzheng Peiyuan and Huanglian Jiedu decoctions, have demonstrated immunomodulatory and anti-myeloma effects in vivo and in human cohorts. These synergistic actions may enhance the efficacy and tolerability of PIs in MM therapy. Conclusion: Integrating TCM with proteasome inhibitors represents a promising strategy to optimize MM treatment by simultaneously targeting malignant cells and the tumor microenvironment. Further mechanistic research and well-designed clinical trials are warranted to validate and standardize this combinational approach for broader clinical adoption.
- Open Access
- 22 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (47) , e40542
Causal effect of primary sclerosing cholangitis on diffuse large B-cell lymphoma: A two-sample Mendelian randomized study
The connection between Primary sclerosing cholangitis (PSC) and lymphoma remains uncertain. To address this, Mendelian randomization (MR) was utilized to investigate the potential causal links between PSC and lymphoma. A 2-sample MR analysis was conducted utilizing summary-level data obtained from genome-wide association study datasets. Four complementary MR methods were performed, including inverse-variance weighting (IVW), MR-Egger, weighted median, and MR-robust adjusted profile score (MR-RAPS). Several sensitivity analyses were also employed to further validate the results. The results of IVW estimates showed that there was a potential causal association between PSC and diffuse large B-cell lymphoma (DLBCL) risk (OR = 1.138, 95% CI = 1.052–1.230, P = .001). No causal association was observed between PSC and other lymphoma subtypes. No horizontal and directional pleiotropy was observed in the MR studies. This study represents the inaugural utilization of MR analysis to investigate the causal associations between PSC and DLBCL. Further investigation is warranted to elucidate the underlying mechanism of this causal relationship.
- 22 November 2024
- Published by Wolters Kluwer Health in Medicine
- Vol. 103 (47) , e40542
Open AccessCausal effect of primary sclerosing cholangitis on diffuse large B-cell lymphoma: A two-sample Mendelian randomized study
The connection between Primary sclerosing cholangitis (PSC) and lymphoma remains uncertain. To address this, Mendelian randomization (MR) was utilized to investigate the potential causal links between PSC and lymphoma. A 2-sample MR analysis was conducted utilizing summary-level data obtained from genome-wide association study datasets. Four complementary MR methods were performed, including inverse-variance weighting (IVW), MR-Egger, weighted median, and MR-robust adjusted profile score (MR-RAPS). Several sensitivity analyses were also employed to further validate the results. The results of IVW estimates showed that there was a potential causal association between PSC and diffuse large B-cell lymphoma (DLBCL) risk (OR = 1.138, 95% CI = 1.052–1.230, P = .001). No causal association was observed between PSC and other lymphoma subtypes. No horizontal and directional pleiotropy was observed in the MR studies. This study represents the inaugural utilization of MR analysis to investigate the causal associations between PSC and DLBCL. Further investigation is warranted to elucidate the underlying mechanism of this causal relationship.
- Open Access
- 21 October 2023
- Published by Springer Nature in Annals of Hematology
- Vol. 103 (2) , 689-691
Comment on: Association between anemia and depression: results from NHANES 2005–2018 and Mendelian randomization analyses
- 21 October 2023
- Published by Springer Nature in Annals of Hematology
- Vol. 103 (2) , 689-691
Open AccessComment on: Association between anemia and depression: results from NHANES 2005–2018 and Mendelian randomization analyses
- Open Access
- 28 February 2022
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 9, 811028
Classification of Diabetic Foot Ulcers Using Class Knowledge Banks
Diabetic foot ulcers (DFUs) are one of the most common complications of diabetes. Identifying the presence of infection and ischemia in DFU is important for ulcer examination and treatment planning. Recently, the computerized classification of infection and ischaemia of DFU based on deep learning methods has shown promising performance. Most state-of-the-art DFU image classification methods employ deep neural networks, especially convolutional neural networks, to extract discriminative features, and predict class probabilities from the extracted features by fully connected neural networks. In the testing, the prediction depends on an individual input image and trained parameters, where knowledge in the training data is not explicitly utilized. To better utilize the knowledge in the training data, we propose class knowledge banks (CKBs) consisting of trainable units that can effectively extract and represent class knowledge. Each unit in a CKB is used to compute similarity with a representation extracted from an input image. The averaged similarity between units in the CKB and the representation can be regarded as the logit of the considered input. In this way, the prediction depends not only on input images and trained parameters in networks but the class knowledge extracted from the training data and stored in the CKBs. Experimental results show that the proposed method can effectively improve the performance of DFU infection and ischaemia classifications.
- 28 February 2022
- Published by Frontiers Media SA in Frontiers in Bioengineering and Biotechnology
- Vol. 9, 811028
Open AccessClassification of Diabetic Foot Ulcers Using Class Knowledge Banks
Diabetic foot ulcers (DFUs) are one of the most common complications of diabetes. Identifying the presence of infection and ischemia in DFU is important for ulcer examination and treatment planning. Recently, the computerized classification of infection and ischaemia of DFU based on deep learning methods has shown promising performance. Most state-of-the-art DFU image classification methods employ deep neural networks, especially convolutional neural networks, to extract discriminative features, and predict class probabilities from the extracted features by fully connected neural networks. In the testing, the prediction depends on an individual input image and trained parameters, where knowledge in the training data is not explicitly utilized. To better utilize the knowledge in the training data, we propose class knowledge banks (CKBs) consisting of trainable units that can effectively extract and represent class knowledge. Each unit in a CKB is used to compute similarity with a representation extracted from an input image. The averaged similarity between units in the CKB and the representation can be regarded as the logit of the considered input. In this way, the prediction depends not only on input images and trained parameters in networks but the class knowledge extracted from the training data and stored in the CKBs. Experimental results show that the proposed method can effectively improve the performance of DFU infection and ischaemia classifications.
- 1 January 2016
- Published by Elsevier in Experimental Cell Research
- Vol. 340 (1) , 22-31
Apoptosis in human myelodysplastic syndrome CD34+ cells is modulated by the upregulation of TLRs and histone H4 acetylation via a β-arrestin 1 dependent mechanism
- 1 January 2016
- Published by Elsevier in Experimental Cell Research
- Vol. 340 (1) , 22-31
Apoptosis in human myelodysplastic syndrome CD34+ cells is modulated by the upregulation of TLRs and histone H4 acetylation via a β-arrestin 1 dependent mechanism
- 31 August 2011
- Published by Elsevier in Complementary Therapies in Clinical Practice
- Vol. 17 (3) , 152-156
Traditional Chinese herbal medicine in the supportive management of patients with chronic cytopaenic marrow diseases – A phase I/II clinical study
- 31 August 2011
- Published by Elsevier in Complementary Therapies in Clinical Practice
- Vol. 17 (3) , 152-156
Traditional Chinese herbal medicine in the supportive management of patients with chronic cytopaenic marrow diseases – A phase I/II clinical study
- 1 August 2011
- Vol. 31 (8) , 1038-40
[Chinese medicine strategies for treating immunologic thrombocytopenia].
- 1 August 2011
- Vol. 31 (8) , 1038-40
[Chinese medicine strategies for treating immunologic thrombocytopenia].
- 1 November 2006
- Vol. 26 (11) , 973-7
[Changes in T-cell receptor repertoire in aplastic anemia and effects of Shengxue Mixture].
To explore the immune pathogenesis of aplastic anemia (AA) and the therapeutic effects of Shengxue Mixture (SM) through the gene expressions of subfamilies of T-cell receptor variable region beta (TCR Vbeta) using immunologic and molecular biologic technology. Gene expressions of TCR Vbeta sub-families in peripheral blood mononuclear cells from 20 AA patients were detected before and after treatment with SM using RT-PCR and gene scanning method. TCR Vbeta gene repertoire of the 24 subfamily genes deviated in AA patients, and the oligoclonal gene expressions increased obviously compared with those in healthy people (P < 0.01), including Vbeta2, 5, 6, 15, 16, 22, and 23 were found in 30%-50% AA patients, and Vbeta8, 21 were in more than 50% patients. These oligoclonal genes reduced significantly after treatment with SM compared with those before treatment (P < 0.05). Multiple TCR Vbeta subfamilies of clonal proliferation participate in the pathogenesis of AA. SM can rectify the deviation of TCR Vbeta gene repertoire, reduce the abnormal clonal proliferation of T cells, thus to alleviate the immune injury to hematopoietic tissue, and thus to benefit the recovery of hematopoiesis of bone marrow.
- 1 November 2006
- Vol. 26 (11) , 973-7
[Changes in T-cell receptor repertoire in aplastic anemia and effects of Shengxue Mixture].
To explore the immune pathogenesis of aplastic anemia (AA) and the therapeutic effects of Shengxue Mixture (SM) through the gene expressions of subfamilies of T-cell receptor variable region beta (TCR Vbeta) using immunologic and molecular biologic technology. Gene expressions of TCR Vbeta sub-families in peripheral blood mononuclear cells from 20 AA patients were detected before and after treatment with SM using RT-PCR and gene scanning method. TCR Vbeta gene repertoire of the 24 subfamily genes deviated in AA patients, and the oligoclonal gene expressions increased obviously compared with those in healthy people (P < 0.01), including Vbeta2, 5, 6, 15, 16, 22, and 23 were found in 30%-50% AA patients, and Vbeta8, 21 were in more than 50% patients. These oligoclonal genes reduced significantly after treatment with SM compared with those before treatment (P < 0.05). Multiple TCR Vbeta subfamilies of clonal proliferation participate in the pathogenesis of AA. SM can rectify the deviation of TCR Vbeta gene repertoire, reduce the abnormal clonal proliferation of T cells, thus to alleviate the immune injury to hematopoietic tissue, and thus to benefit the recovery of hematopoiesis of bone marrow.